查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1287471

骨關節炎治療藥物市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

2022年，全球骨關節炎治療劑市場規模達到73億美元。展望未來，IMARC集團預計，到2028年，市場規模將達到117億美元，在2023-2028年期間呈現8.2%的成長率（CAGR）。

骨關節炎（OA）是一種異質性疾病，其特點是膝蓋、臀部、手、腳、脊柱、肩膀和頸部等關節的軟骨逐漸退化。 OA通常會造成僵硬、腫脹、觸痛、持續疼痛、失去靈活性、磨擦感、骨刺和睡眠障礙。可以透過體檢、X光、關節鏡、關節液分析、血液檢查和磁共振成像（MRI）掃描來診斷。根據不同的結果開出各種藥物和手術治療，以緩解該疾病的症狀和體徵。目前，市場上有替代藥物、物理療法和支援性設備來緩解疼痛和改善關節功能。

全球骨關節炎治療藥物的市場趨勢和驅動因素：

久坐的生活方式，不健康的飲食模式，以及肥胖和血糖的流行率上升，都增加了個人患OA的風險。再加上老年人口不斷增加，更容易受到這種疾病的影響，這是推動骨關節炎治療方法市場成長的關鍵因素之一。除此之外，MRI掃描的便利性也是另一個主要的成長誘因。此外，基於放射學特徵的成像生物標記的開發，加上鎮痛藥物的引進，促進市場成長。此外，為推出新的診斷方法和生物標記而進行的研究和開發（R&D）活動的投資增加，以及改善醫療基礎設施的支出增加，也推動市場。例如，開發改變疾病的藥物，其重點是用於治療軟骨崩潰的促炎症細胞因子。

本報告中回答的關鍵問題：

  • 迄今為止，全球骨關節炎治療劑市場的表現如何，在未來幾年將如何表現？
  • COVID-19對全球骨關節炎治療劑市場的影響是什麼？
  • 主要的區域市場是什麼？
  • 基於解剖學類型的市場細分是什麼？
  • 基於藥物類型的市場細分是什麼？
  • 基於給藥途徑的市場細分是什麼？
  • 基於配銷通路的市場細分是什麼？
  • 該行業價值鏈的各個階段是什麼？
  • 該行業的關鍵驅動因素和挑戰是什麼？
  • 全球骨關節炎治療劑市場的結構是什麼，誰是主要參與者？
  • 該行業的競爭程度如何？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 資料來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球骨關節炎治療藥物市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按解剖學類型分類的市場

  • 膝關節
    • 市場趨勢
    • 市場預測
  • 髖關節
    • 市場趨勢
    • 市場預測
  • 手部
    • 市場趨勢
    • 市場預測
  • 脊柱
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：按藥物類型分類的市場

  • 非類固醇抗發炎藥
    • 市場趨勢
    • 市場預測
  • 鎮痛藥
    • 市場趨勢
    • 市場預測
  • 皮質類固醇
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按給藥途徑分類的市場

  • 靜脈注射
    • 市場趨勢
    • 市場預測
  • 外用藥
    • 市場趨勢
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測

第九章：按配銷通路分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 專科診所
    • 市場趨勢
    • 市場預測
  • 醫療機構
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第十章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳洲
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十二章：價值鏈分析

第十三章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章：價格分析

第十五章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abbott Laboratories
    • Anika Therapeutics Inc.
    • Bayer Aktiengesellschaft
    • Eli Lilly and Company
    • Flexion Therapeutics Inc.
    • GlaxoSmithKline Plc
    • Horizon Therapeutics Plc
    • Johnson & Johnson Inc.
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR1623A172_Report

Market Overview:

The global osteoarthritis therapeutics market size reached US$ 7.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028.

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Global Osteoarthritis Therapeutics Market Trends and Drivers:

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoarthritis therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on anatomy type, drug type, route of administration and distribution channel.

Breakup by Anatomy Type:

  • Knee
  • Hip
  • Hand
  • Spine
  • Others

Breakup by Drug Type:

  • Nonsteroidal Anti-Inflammatory Drugs
  • Analgesics
  • Corticosteroids
  • Others

Breakup by Route of Administration:

  • Parenteral
  • Topical
  • Oral

Breakup by Distribution Channel:

  • Hospitals
  • Specialty Clinics
  • Medical Institutions
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:

  • How has the global osteoarthritis therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the anatomy type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global osteoarthritis therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Anatomy Type

  • 6.1 Knee
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hand
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Spine
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Nonsteroidal Anti-Inflammatory Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Analgesics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Corticosteroids
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Parenteral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Topical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oral
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Medical Institutions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Anika Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Eli Lilly and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Flexion Therapeutics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 GlaxoSmithKline Plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Horizon Therapeutics Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2022
  • Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million US$), 2017 & 2022

Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million US$), 2023-2028

  • Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
  • Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
  • Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million US$), 2023-2028
  • Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
  • Table 8: Global: Osteoarthritis Therapeutics Market: Key Players